-
EP3870230
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3870230
| EP3870230 - CONJUGATES OF BILE ACIDS AND THEIR DERIVATIVES FOR ACTIVE MOLECULES DELIVERY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 20.05.2022 Database last updated on 17.07.2024 | |
| Former | Request for examination was made Status updated on 30.07.2021 | ||
| Former | The international publication has been made Status updated on 02.05.2020 | ||
| Former | unknown Status updated on 03.12.2019 | Most recent event Tooltip | 09.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Finice S.r.l. Via Sicilia, 6 42122 Reggio Emilia / IT | [2021/35] | Inventor(s) | 01 /
PALMIERI, Beniamino Via Bisi, 125 41120 Modena / IT | 02 /
BOVOLENTA, Matteo Via Dante Alighieri, 28 44049 Vigarano Pieve (FE) / IT | 03 /
BRAGHETTA, Paola c/o Dipartimento di Medicina Molecolare - Università degli Studi di Padova - Via U. Bassi 58/B 35121 Padova / IT | 04 /
CAPOBIANCO, Massimo Luigi c/o ISOF-CNR - Via Gobetti, 101 40129 Bologna / IT | 05 /
MARCHESI, Elena c/o Dipartimento di Scienze Chimiche e Farmaceutiche Università degli Studi di Ferrara Via L. Borsari, 46 44121 Ferrara / IT | 06 /
MEDICI, Alessandro Via Libia, 10 40138 Bologna / IT | 07 /
MOLON, Sibilla Via Filippo Turati, 90 36045 Lonigo (VI) / IT | 08 /
PERRONE, Daniela c/o Dipartimento di Scienze Chimiche e Farmaceutiche Università degli Studi di Ferrara Via L. Borsari, 46 44121 Ferrara / IT | 09 /
RIMESSI, Paola c/o Azienda Ospedaliero Universitaria di Ferrara Via Fossato di Mortara, 74 44121 Ferrara / IT | [2021/35] | Representative(s) | Studio Torta S.p.A., et al Via Viotti, 9 10121 Torino / IT | [N/P] |
| Former [2021/35] | Casciano, Lidia Giulia Rita, et al Studio Torta S.p.A. Via Viotti, 9 10121 Torino / IT | Application number, filing date | 19808885.8 | 22.10.2019 | [2021/35] | WO2019IB59014 | Priority number, date | IT20180009682 | 22.10.2018 Original published format: IT201800009682 | [2021/35] | Filing language | IT | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020084488 | Date: | 30.04.2020 | Language: | EN | [2020/18] | Type: | A1 Application with search report | No.: | EP3870230 | Date: | 01.09.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.04.2020 takes the place of the publication of the European patent application. | [2021/35] | Search report(s) | International search report - published on: | EP | 30.04.2020 | Classification | IPC: | A61K47/54, A61P21/00 | [2021/35] | CPC: |
A61K47/554 (EP,US);
C12N15/1138 (US);
A61P21/00 (EP,US);
C12N2310/14 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/35] | Title | German: | KONJUGATE VON GALLENSÄUREN UND DEREN DERIVATE ZUR VERABREICHUNG VON AKTIVEN MOLEKÜLEN | [2021/35] | English: | CONJUGATES OF BILE ACIDS AND THEIR DERIVATIVES FOR ACTIVE MOLECULES DELIVERY | [2021/35] | French: | CONJUGUÉS D'ACIDES BILIAIRES ET DE LEURS DÉRIVÉS POUR L'ADMINISTRATION DE MOLÉCULES ACTIVES | [2021/35] | Entry into regional phase | 26.04.2021 | National basic fee paid | 26.04.2021 | Designation fee(s) paid | 26.04.2021 | Examination fee paid | Examination procedure | 26.04.2021 | Examination requested [2021/35] | 26.04.2021 | Date on which the examining division has become responsible | 09.11.2021 | Amendment by applicant (claims and/or description) | 19.05.2022 | Despatch of a communication from the examining division (Time limit: M04) | 22.09.2022 | Reply to a communication from the examining division | 13.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 28.10.2021 | Renewal fee patent year 03 | 24.10.2022 | Renewal fee patent year 04 | 23.10.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2014323544 (BESTWICK RICHARD K [US], et al) [A] 1-15 * paragraphs [0016] , [ 0032] , [ 0145] * * claim 32 *; | [A]WO2018031933 (UNIV MASSACHUSETTS [US]) [A] 1-15* Figure 37 on sheet 62/97 *; | [A] - LEHMANN T J ET AL, "Synthesis and Properties of Bile Acid Phosphoramidites 5'-Tethered to Antisense Oligodeoxynucleotides against HCV", BIOORGANIC & MEDICINAL CHEMISTRY : A TETRAHEDRON PUBLICATION FOR THE RAPID DISSEMINATION OF FULL ORIGINAL RESEARCH PAPERS AND CRITICAL REVIEWS ON BIOMOLECULAR CHEMISTRY, MEDICINAL CHEMISTRY AND RELATED DISCIPLINES, ELSEVIER, NL, vol. 9, no. 7, ISSN 0968-0896, (20010701), pages 1827 - 1835, (20010701), XP027414418 [A] 1-15 * whole document and in particular the abstract and Scheme 3 * | [A] - DEBART F ET AL, "Chemical modifications to improve the cellular uptake of oligonucleotides", CURRENT TOPICS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD.HILVERSUM, NL, (20070101), vol. 7, no. 7, doi:10.2174/156802607780487704, ISSN 1568-0266, pages 727 - 737, XP002562043 [A] 1-15 * whole document and in particular Figure 3 and page 729, right-hand column, 3rd paragraph * DOI: http://dx.doi.org/10.2174/156802607780487704 | [A] - MANOHARAN M ET AL, "CHEMICAL MODIFICATIONS TO IMPROVE UPTAKE AND BIOAVAILABILITY OF ANTISENSE OLIGONUCLEOTIDES", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, US, (19920101), vol. 660, doi:10.1111/J.1749-6632.1992.TB21095.X, ISSN 0077-8923, pages 306 - 309, XP000198020 [A] 1-15 * whole document and in particular Figure 1 * DOI: http://dx.doi.org/10.1111/j.1749-6632.1992.tb21095.x |